Individuals with asymptomatic AD (Asym AD) included in this analysis exhibited minimal cognitive impairment with moderate to high amyloid plaque frequency but with low to no cortical tau pathology (Table S4) [37]. This evidence concerns the gene MAPT and Cognitive impairment.